Pharmaceuticals, Biotechnology and Life Sciences
— Data expected by end of 2019 — HIGH POINT, N.C.–(BUSINESS WIRE)–Banner Life Sciences LLC (Banner), a privately held specialty…
NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) today announced that the Company has exercised its option and entered into an…
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV) today announced it has received the Frost & Sullivan’s 2018 Global…
Company receives additional AU$10m to continue clinical development of biodegradable eye implant CHICAGO–(BUSINESS WIRE)–PolyActiva Pty Ltd, a clinical-stage biotechnology company…
Company will use proceeds to advance potential first-in-class drug candidate for hearing restoration and discovery programs using its Progenitor Cell…
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…
JNDA Submission Represents First Regulatory Submission for Marketing Approval of Vadadustat CAMBRIDGE, Mass.–(BUSINESS WIRE)–Akebia Therapeutics, Inc. (Nasdaq: AKBA), today announced…
SEATTLE–(BUSINESS WIRE)–LifeSpan BioSciences, Inc. (LSBio™), the industry leader in molecular pathology, today announced the first release of its PathPlus™ series…
Sinomed has completed enrollment in the PIONEER III randomized, controlled clinical trial testing the BuMA Supreme DES and support U.S. and Japanese regulatory approvals for the treatment of atherosclerotic coronary lesions.
LUGANO, Switzerland & BELLINZONA, Switzerland & GARDANNE, France–(BUSINESS WIRE)–Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to…